Rapport Therapeutics, Inc. (RAPP) Operating income 2023–2025
Rapport Therapeutics, Inc. (RAPP) annual operating income history from SEC filings — each fiscal year as reported.
-$125.1MFY2025 · since FY2023: -$36.2M → -$125.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$125.1M | -50.6% |
| FY2024 | -$83.1M | -129.6% |
| FY2023 | -$36.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RAPP financial trends
RAPP RevenueRAPP Net incomeRAPP Net marginRAPP Gross profitRAPP Gross marginRAPP Operating marginRAPP Operating cash flowRAPP Free cash flowRAPP Capital expendituresRAPP Return on equityRAPP Stock buybacksRAPP Dividends paidRAPP Total assetsRAPP Total liabilitiesRAPP Shareholders’ equityRAPP overview →